|
|
VTPT: an expert overview January 2009
Recently, respected experts from prostate cancer field published an important review of the current evidence surrounding the application of a number of the new and/or evolving treatments available such as newer technique known as vascular-targeted photodynamic therapy (VTPT).
They make the following key points:
- VTPT is another promising technique, currently in clinical trials.
- VTPT has been used for whole gland ablation of locally recurrent cancer after radiotherapy and for focal ablation of previously untreated cancer.
- In combination with a new, systemically administered photodynamic agent, laser light is delivered through fibers introduced into the prostate under ultrasound guidance.
- This technique does not heat the prostate but destroys the endothelial cells and cancer by activating the photodynamic agent.
- Damage to surrounding structures appears to be limited and can be controlled by the duration and intensity of the light.
NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for
information only, and are not meant to substitute for the advice of your own physician or other medical professional.
Prostate-Report.org does not endorse any specific product, service or treatment.
|
|
|
